{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:22:02Z","timestamp":1791184922403,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Institut National du Cancer (INCa)"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.bulcan.2015.03.012","type":"journal-article","created":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T01:03:33Z","timestamp":1430010213000},"page":"463-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Grossesse apr\u00e8s cancer\u00a0: pour qui et quand\u00a0?"],"prefix":"10.1016","volume":"102","author":[{"given":"Anne Laure","family":"Margulies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Selleret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Thomassin","family":"Nagarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Chopier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gligorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Berveiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Darai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2015.03.012_bib0265","first-page":"17","article-title":"[Breast cancer and fertility: critical review, considerations and perspectives]","volume":"95","author":"This","year":"2008","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0270","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.suronc.2009.03.009","article-title":"Pregnancy after breast cancer: a need for global patient care, starting before adjuvant therapy","volume":"19","author":"Chabbert-Buffet","year":"2010","journal-title":"Surg Oncol"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.bulcan.2015.03.012_bib0275","first-page":"S175","article-title":"Fertility and adjuvant treatment in young women with breast cancer","volume":"16","author":"Partridge","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0280","series-title":"Institut National du Cancer, Plan Cancer 2014-2019, ref PLANK14","year":"2014"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0285","first-page":"487","article-title":"[Fertility preservation in cancer women: a multidisciplinary approach]","volume":"40","author":"Treves","year":"2011","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0290","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/107327480200900603","article-title":"Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer","volume":"9","author":"Minton","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0295","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1245\/s10434-010-1172-3","article-title":"The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up","volume":"17","author":"Jung","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0300","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.ejca.2007.04.006","article-title":"Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI","volume":"43","author":"Partridge","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-010-1235-y","article-title":"Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and\/or tamoxifen in the BIG 1-98\u00a0trial","volume":"126","author":"Phillips","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0310","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0315","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2010.04.006","article-title":"Correlation of ovarian reserve tests with histologically determined primordial follicle number","volume":"95","author":"Hansen","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0320","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0325","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/ERC-13-0335","article-title":"Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients","volume":"21","author":"Bozza","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0330","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-540-71274-9_18","article-title":"Fertility issues and options in young women with cancer","volume":"178","author":"Oktay","year":"2008","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3810\/pgm.2004.10.1598","article-title":"Care of the breast cancer survivor: increased survival rates present a new set of challenges","volume":"116","author":"McCarthy","year":"2004","journal-title":"Postgrad Med"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0340","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc1992","article-title":"Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants","volume":"6","author":"Stearns","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0345","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8","article-title":"Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer","volume":"39","author":"Koyama","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0350","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clon.2008.03.016","article-title":"Epirubicin\/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function","volume":"20","author":"Zekri","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0355","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10549-008-0071-9","article-title":"Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer","volume":"115","author":"Han","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0360","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.fertnstert.2009.03.045","article-title":"Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer","volume":"94","author":"Partridge","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0365","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/humrep\/des188","article-title":"The current fertility preservation consultation model: are we adequately informing cancer patients of their options?","volume":"27","author":"Balthazar","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0370","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10815-014-0183-6","article-title":"Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram","volume":"31","author":"Devesa","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0375","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra050776","article-title":"Estrogen carcinogenesis in breast cancer","volume":"354","author":"Yager","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0380","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1634\/theoncologist.11-5-422","article-title":"Fertility preservation in young women undergoing breast cancer therapy","volume":"11","author":"Sonmezer","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0385","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","article-title":"Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study","volume":"26","author":"Azim","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0390","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1200\/JCO.2006.06.9823","article-title":"Measuring the impact of chemotherapy on fertility in women with breast cancer","volume":"24","author":"Oktay","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0395","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0400","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/humupd\/dmr004","article-title":"GnRH antagonists are safer than agonists: an update of a Cochrane review","volume":"17","author":"Al-Inany","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0405","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1472-6483(10)60025-9","article-title":"Over 900\u00a0oocyte cryopreservation babies born with no apparent increase in congenital anomalies","volume":"18","author":"Noyes","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0410","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.fertnstert.2013.03.030","article-title":"Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60\u00a0cases of reimplantation","volume":"99","author":"Donnez","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0415","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","article-title":"How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries","volume":"12","author":"Blumenfeld","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0420","first-page":"1961","article-title":"[Pregnancy after treated breast cancer. Results of a case-control study]","volume":"15","author":"Mignot","year":"1986","journal-title":"Presse Med"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0425","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0002-9378(94)70290-X","article-title":"Survival of breast cancer patients after subsequent term pregnancy: \u201chealthy mother effect\u201d","volume":"170","author":"Sankila","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0430","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bmj.39035.667176.55","article-title":"Pregnancy after breast cancer: population based study","volume":"334","author":"Ives","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0435","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.gyobfe.2008.06.025","article-title":"[Pregnancy after breast cancer: the obstetrician's point of view. Literature review]","volume":"36","author":"Werkoff","year":"2008","journal-title":"Gynecol Obstet Fertil."},{"key":"10.1016\/j.bulcan.2015.03.012_bib0440","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-0897.1998.tb00365.x","article-title":"How might pregnancy immunize against breast cancer?","volume":"39","author":"Botelho","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0445","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnci\/djh211","article-title":"Breast-feeding and the risk of breast cancer in BRCA1\u00a0and BRCA2\u00a0mutation carriers","volume":"96","author":"Jernstrom","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0450","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ijc.21273","article-title":"Effect of pregnancy as a risk factor for breast cancer in BRCA1\/BRCA2\u00a0mutation carriers","volume":"117","author":"Cullinane","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0455","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jnci\/djj132","article-title":"Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1\/2\u00a0Carrier Cohort Study (IBCCS)","volume":"98","author":"Andrieu","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.bulcan.2015.03.012_bib0460","article-title":"Place du diagnostic pr\u00e9natal, de l\u2019interruption m\u00e9dicale de grossesse et du diagnostic pr\u00e9implantatoire dans les formes h\u00e9r\u00e9ditaires de cancer","volume":"12","author":"Stoppa-Lyonnet","year":"2010","journal-title":"Med Ther"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0465","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10549-014-2951-5","article-title":"Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors","volume":"145","author":"Derks-Smeets","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0470","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1701-2163(16)30298-5","article-title":"Breast cancer, pregnancy, and breastfeeding","volume":"24","author":"Helewa","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0475","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2301::AID-CNCR1>3.0.CO;2-A","article-title":"Pregnancy after breast carcinoma: the ultimate medical challenge","volume":"85","author":"Averette","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0480","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.seminoncol.2006.08.015","article-title":"Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancer","volume":"33","author":"Park","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0485","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gyobfe.2014.01.005","article-title":"[Breastfeeding after breast cancer: survey to hospital health professionals in Alsace]","volume":"42","author":"Goetz","year":"2014","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0490","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000421-199502000-00008","article-title":"Lactation after conservative breast surgery combined with radiation therapy","volume":"18","author":"Tralins","year":"1995","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0495","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00130404-200509000-00007","article-title":"Effects of breast-conserving therapy on lactation after pregnancy","volume":"11","author":"Moran","year":"2005","journal-title":"Cancer J"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0500","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11764-009-0089-y","article-title":"A qualitative investigation of breast cancer survivors\u2019 experiences with breastfeeding","volume":"3","author":"Gorman","year":"2009","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0505","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00006534-200002000-00008","article-title":"Breast-feeding after inferior pedicle reduction mammaplasty","volume":"105","author":"Brzozowski","year":"2000","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0510","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.maturitas.2010.03.027","article-title":"Sexuality after breast cancer: a review","volume":"66","author":"Gilbert","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0515","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1524-4741.2009.00766.x","article-title":"Quality of life after breast cancer: survivorship and sexuality","volume":"15","author":"Dizon","year":"2009","journal-title":"Breast J"},{"key":"10.1016\/j.bulcan.2015.03.012_bib0260","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/pon.685","article-title":"The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study","volume":"12","author":"Thewes","year":"2003","journal-title":"Psychooncology"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115001307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115001307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T03:48:53Z","timestamp":1566618533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115001307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0007455115001307"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.03.012","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Grossesse apr\u00e8s cancer\u00a0: pour qui et quand\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}